Skip to Content
Merck
  • Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes.

Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes.

Hybridoma (1984-01-01)
C B Reimer, D J Phillips, C H Aloisio, D D Moore, G G Galland, T W Wells, C M Black, J S McDougal
ABSTRACT

Stable clones of 31 mouse hybridomas that produce monoclonal antibodies (MAbs) against human IgG antigenic determinants were obtained. The number of hybridomas of different specificity described are: 2 anti-IgG1 Fc, 1 anti-IgG2 Fc, 1 anti-IgG2 Fd, 2 anti-IgG3 Fc, 2 anti-IgG3 hinge, 3 anti-IgG4 Fc, 3 anti-IgG4 Fd, 2 anti-nG4m(b), 4 anti-IgGFc, 2 anti-IgGFd, 1 anti-kappa, 1 anti-lambda, 1 anti-non IgG1, 2 anti-non IgG2, 2 anti-non-IgG3, 2 anti-non-IgG4. Evidence is presented validating their specificity. Some MAbs demonstrated to be avid, potent, and specific for well defined IgG-subclass epitopes may be partially or completely inactive in other assay systems, presumably because of different presentations of antigen epitopes. In general, this problem requires careful writing of protocols describing the use of MAbs.

MATERIALS
Product Number
Brand
Product Description

HP 6053, Reactivity: Anti-κ-Chain, human, 94050510